GTx, Inc. Muscle Drug Boosts Lean Body Mass in Mid-stage Trial

Reuters -- GTx Inc said patients with cancer-induced muscle loss, or cancer cachexia, gained as much as 1.5 kilograms of muscle in a mid-stage trial of its experimental drug Ostarine.
MORE ON THIS TOPIC